Novus Therapeutics, Inc.

Ticker NVUS

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

1-10 Employees
Based in Irvine, California

Novus Therapeutics, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for organ or cellular transplantation, as well as for autoimmune and neurodegenerative diseases. Novus is headquartered in Irvine, Calif.

Visit website

REPORT RATINGS

4.8 / 5.0 (182)

Novus Therapeutics, Inc. reports have an aggregate usefulness score of 4.8 based on 182 reviews.

Novus Therapeutics, Inc.